ESC Premium Access

Optimizing Risk Stratification and Technical Aspects of TAVI Procedures

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Aortic Valve Intervention
Session type: Rapid Fire Abstracts
Date: 31 August 2020
Time: 08:30 - 08:30

Session

9 presentations in this session

The adverse impact of HFpEF in patients with aortic stenosis: Evaluation of the H2FPEF score for risk assessment among patients with preserved ejection fraction undergoing TAVI

Speaker: Mr S. Ludwig (Hamburg, DE)
Thumbnail

Incremental prognostic value of tricuspid annular dilatation over the STS score

Speaker: Doctor S. Deseive (Munich, DE)
Thumbnail

Predictors of haemodynamic performance in patients with aortic stenosis and small annulus undergoing TAVI with self-expandable valves

Speaker: Doctor M. Chiarito (New York, US)
Thumbnail

Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis treated with transcatheter valve replacement: insights from the BEAT international collaborative registry

Speaker: Doctor A. Ielasi (Milan, IT)
Thumbnail

A novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves

Speaker: Doctor A. Snir (Sydney, AU)
Thumbnail

Impact of the timing of coronary revascularization relative to the transcatheter aortic valve implantation procedure: insights from a propensity score analysis based on a nationwide analysis

Speaker: Professor P. Lantelme (Lyon, FR)
Thumbnail

How safe are current expert consensus recommendations for discharge after TAVI?

Speaker: Doctor F. De Torres Alba (Munster, DE)
Thumbnail

Silent cerebral embolisation during TAVI: evolution, predictors and neurocognitive effects

Speaker: Doctor M. De Carlo (Pisa, IT)
Thumbnail

Randomized clinical trial comparing a rivaroxaban-based with an antiplatelet-based strategy for cerebral embolization after TAVR (EARTH TAVR)-a magnetic resonance imaging substudy of the GALILEO trial

Speaker: Doctor G. Froehlich (Berlin, DE)
Thumbnail

9 speakers from this session

Mr Sebastian Ludwig

University Heart & Vascular Center Hamburg, Hamburg (Germany)
1 presentation
0 follower

Doctor Simon David Christopher Deseive

University Hospital of Munich, Munich (Germany)
0 follower

Doctor Mauro Chiarito

Icahn School of Medicine at Mount Sinai, New York (United States of America)
0 follower

Doctor Alfonso Ielasi

Clinical Institute Saint Ambrogio, Milan (Italy)
0 follower

Doctor Afik Snir

Macquarie University Hospital, Sydney (Australia)
0 follower

Professor Pierre Lantelme

Croix-Rousse Hospital - HCL, Lyon (France)
0 follower

Doctor Fernando De Torres Alba

University Hospital of Munster, Munster (Germany)
0 follower

Doctor Marco De Carlo

Azienda Ospedaliero Universitaria Pisana, Pisa (Italy)
6 presentations
0 follower

Doctor Georg Marcus Froehlich

Charite - Campus Benjamin Franklin, Berlin (Germany)
0 follower

This platform is supported by

logo Novo Nordisk